Abstract
*The following committee members were nominated by the Council on Dental Therapeutics and appointed by President Bentley: Dr. Major M. Ash, Jr., Professor and Chairman, Department of Occlusion, School of Dentistry, University of Michigan; Dr. Mohandas Bhat, Assistant Professor, Department of Community Dentistry, Case Western Reserve University; Dr. Nabil Bissada, Professor and Chairman, Department of Periodontics, School of Dentistry, Case Western Reserve University; Dr. Sebastian G. Ciancio, Professor and Chairman, Department of Periodontics, School of Dentistry, State University of New York at Buffalo; Dr. Louis P. Gangarosa, Professor and Coordinator of Pharmacology, School of Dentistry, Medical College of Georgia; Dr. Hans Graf, Chairman, Department of Periodontology, School of Dentistry, University of Bern (Switzerland); Dr. Isreal Klineberg, Chairman, Department of Oral Biology and Pathology, School of Dentistry, State University of New York at Stony Brook; Dr. Joseph A. Kanapka, Assistant Director, Dental Research, Vicks Research Center; Dr. Synguck Kim, Assistant Professor, Department of Endodontics, College of Dental and Oral Surgery, Colombia University; Dr. Walter T. McFall, Jr., Professor, Department of Periodontology, School of Dentistry, University of North Carolina; Dr. Patricia A. McGrath, Director, Pain Research Unit, Department of Oral Biology, Faculty of Dentistry, University of Western Ontario; Dr. David A. Pashley, Professor, Department of Oral Biology‐Physiology, School of Dentistry, Medical College of Georgia; Dr. Gerald Silverman, Private Practice, Hartford, Connecticut.Chairing the committee meeting were the following American Dental Association Staff Members: Dr. Kenneth H. Burrell, Assistant Secretary, Council on Dental Therapeutics; Dr. Conrad A. Naleway, Director, Division of Chemistry, Council on Dental Therapeutics; Dr. Helmut Zander, Special Consultant for Scientific Affairs, American Dental Association.The committee was funded by the American Fund for Dental Health through the support of the Block Drug Company, the John O. Butler Company, the Mentholaltim Company, and Richardson‐Vicks, Inc.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
